Tuesday, December 16, 2025 | 05:59 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Hyderabad's NIMS begins human trials of coronavirus vaccine Covaxin

The healthy volunteers, who were administered the first dose of the vaccine in the morning, were stable.

Covaxin, bharat biotech, covid, coronavirus, vaccine, drugs, medicine, pharma
premium

Health experts have expressed skepticism about the timeline and said government pressure could be behind this

IANS Hyderabad

As part of human trials of Covaxin, India's first indigenous Covid-19 vaccine, two volunteers were given its first dose at the Nizam's Institute of Medical Sciences (NIMS) on Monday, doctors said.

The healthy volunteers, who were administered the first dose of the vaccine in the morning, were stable. "Both are stable and we have not found any reaction or side-effects," said Dr G. Srinivas, a member of the research team conducting the clinical trials.

The volunteers will remain under the observation of a team of doctors till Tuesday. They will be sent home but their condition will be remotely monitored by the